HOME >> MEDICINE >> NEWS
High-dose interferon beta-1b for multiple sclerosis patients

A study published in this weeks issue of THE LANCET suggests that high-dose interferon beta-1b administered every other day is more effective than interferon beta-1a once a week for people with multiple sclerosis (MS).

There are three interferon beta therapies known to be effective in reducing MS symptoms: interferon beta-1a 30 mcg administered intramuscularly once a week; interferon beta-1a 22 mcg or 44 mcg given subcutaneously three times a week; and interferon beta-1b 250 mcg administered subcutaneously on alternate days. However, there is no published research which directly compares the different regimens. Luca Durelli and colleagues from Turin University Medical School, Italy, coordinated a multicentre study in 15 Italian MS centres comparing the clinical and magnetic resonance imaging (MRI) benefits of 250 mcg interferon beta-1b given on alternate days with 30 mcg interferon beta-1a once weekly'.

In a 2-year prospective study, 188 patients with relapsing-remitting MS were randomised to receive either interferon beta-1b or interferon beta-1a. Over 2 years, 51% of individuals administered interferon beta-1b remained relapse-free compared with 36% given interferon beta-1a; 55% compared with 26%, respectively, remained free from new proton density/T2 brain lesions at the MRI assessment.

A second study (p 1461) in this weeks issue of THE LANCET examines a possible association between MS and type-1 diabetes (another autoimmune disease) in Sardinia, a population with little genetic variation. Maria Giovanna Marrosu and colleagues from the Department of Neuroscience, Cagliari, Italy, found that the prevalence of type-1 diabetes in people with MS was around three times greater compared with their healthy siblings, and around five times greater than in the general Sardinian population. In an accompanying Commentary (p 1450), ke Lernmark from the University of Washington, Seattle, USA, discusses how susceptibility to MS often protects against di
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
24-Apr-2002


Page: 1 2

Related medicine news :

1. High-dose radiotherapy could reduce cognitive function for people with low-grade brain tumours
2. High-dose radiation treatment effective at fighting some cancers in children
3. Genes in the interferon system important in SLE
4. Further evidence showing treatment benefits of beta interferon for MS
5. Low-dose interferon fails to improve survival in high-risk melanoma patients
6. Detection of antibodies could identify MS pats who do not respond well to interferon beta
7. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
8. Research suggests possible blood test for multiple sclerosis
9. Mayo Clinic researchers announce promising next generation treatments for multiple myeloma
10. Good fats decrease multiple heart disease risk factors
11. Swallowing multiple magnets poses danger to children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/14/2019)... ... May 14, 2019 , ... Impact Advisors, a ... industry, announced today that John Stanley, Vice President, has been named one of ... for the Western U.S., has been recognized in the Excellence in Healthcare category. ...
(Date:5/14/2019)... ... 14, 2019 , ... A high number of HIV cases among the LGBTQ ... the Houston area and the southern United States. Specifically, the sub-groups at greater ... with men (MSM) and transgender people of color ages 13 to 34. In ...
(Date:5/14/2019)... ... May 14, 2019 , ... Relatient, Inc., a leader in ... Check-In solution , a new product launched to reduce patient wait times and ... Relatient’s Patient Engagement platform introducing earlier touch points on the patient journey ...
(Date:5/14/2019)... ... May 14, 2019 , ... Forty-two billion dollars ... and procedures, according to market analysis company Orbis Research. “Treatments certainly can help,” ... Advanced Dermatology PC , “but for our skin, there’s free super-potent anti-aging care ...
(Date:5/14/2019)... ... 2019 , ... Dr. Steven Shoshany has been treating patients experiencing both acute ... cold laser therapy device, becoming the first chiropractor in Manhattan to do so. Since ... FDA clearances for treating pain and injuries, into his downtown practice. He recently finished ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... NEW YORK (PRWEB) , ... May 16, 2019 ... ... digital health platform and portfolio company of Topspin Partners, today announced the acquisition ... in the diabetes, mental health, back pain, and pain management areas. This acquisition ...
(Date:5/16/2019)... ... May 16, 2019 , ... Luma Health https://www.lumahealth.io/ ... Patient Intake. This new solution helps providers deliver a top-notch patient experience by ... on their device of choice, days or weeks prior to their appointment. By ...
(Date:5/15/2019)... ... May 15, 2019 , ... Claudius ... network’s new Vice President of Information Technology. Over the last 15 years, Moore ... for healthcare systems, while also creating a high-quality, efficient experience for patients. , ...
Breaking Medicine Technology:
Cached News: